These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 447028)

  • 1. Hepatic and pulmonary clearance of exogenous vasoactive intestinal peptide in the rat.
    Humphrey CS; Murray P; Ebeid AM; Fischer JE
    Gastroenterology; 1979 Jul; 77(1):55-60. PubMed ID: 447028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic inactivation of vasoactive intestinal peptide in man and dog.
    Ebeid AM; Escourrou J; Soeters PB; Murray P; Fischer JE
    Ann Surg; 1978 Jul; 188(1):28-33. PubMed ID: 666373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of vasoactive intestinal peptide by rat liver.
    Misbin RI; Wolfe MM; Morris P; Buynitzky SJ; McGuigan JE
    Am J Physiol; 1982 Aug; 243(2):G103-11. PubMed ID: 7051851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
    Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes.
    Ramírez-Cárdenas R; Prieto JC; Guerrero JM; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide down-regulates the intrahepatic renin-angiotensin system in the anaesthetized rat.
    Ye VZ; Duggan KA
    Clin Sci (Lond); 2000 Sep; 99(3):201-6. PubMed ID: 11787472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain.
    Dufes C; Gaillard F; Uchegbu IF; Schätzlein AG; Olivier JC; Muller JM
    Int J Pharm; 2004 Nov; 285(1-2):77-85. PubMed ID: 15488681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide.
    Rorstad OP; Wanke I; Coy DH; Fournier A; Huang M
    Mol Pharmacol; 1990 Jun; 37(6):971-7. PubMed ID: 2163020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach.
    Arany E; Zabel P; Hill DJ
    Growth Regul; 1996 Mar; 6(1):32-41. PubMed ID: 8717448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic clearance of somatostatin and gastrin-releasing peptide.
    Wolfe MM; Doyle JW; McGuigan JE
    Life Sci; 1987 Jan; 40(4):335-42. PubMed ID: 2880271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo dynamical distribution of 131I-VIP in the rat studied by gamma-camera.
    Hassan M; Refai E; Andersson M; Schnell PO; Jacobsson H
    Nucl Med Biol; 1994 Aug; 21(6):865-72. PubMed ID: 9234336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vasoactive intestinal peptide receptor turnover in pulmonary arteries indicates an important role for VIP in the rat lung circulation.
    Petkov V; Gentscheva T; Schamberger C; Haberl I; Artl A; Andreae F; Mosgoeller W
    Ann N Y Acad Sci; 2006 Jul; 1070():481-3. PubMed ID: 16888213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential binding of vasoactive intestinal peptide to hepatic nonparenchymal cells.
    Gardner DF; Kilberg MS; Wolfe MM; McGuigan JE; Misbin RI
    Am J Physiol; 1985 Jun; 248(6 Pt 1):G663-9. PubMed ID: 2988343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of hepatic inactivation of canine vasoactive intestinal peptide.
    Strunz UT; Walsh JH; Bloom SR; Thompson MR; Grossman MI
    Gastroenterology; 1977 Oct; 73(4 Pt 1):768-71. PubMed ID: 892380
    [No Abstract]   [Full Text] [Related]  

  • 16. [The temporal and spatial distribution of vasoactive intestinal peptide and its receptor in the development of airway hyperresponsiveness].
    Ren YH; Qin XQ; Guan CX; Luo ZQ; Zhang CQ; Sun XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):224-8. PubMed ID: 15144609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric release of vasoactive intestinal peptide after a peptone meal in the dog.
    Wolfe MM; Misbin RI; Gardner DF; McGuigan JE
    Regul Pept; 1983 Jan; 5(2):103-9. PubMed ID: 6828775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of vasoactive intestinal peptide in the central nervous system in man.
    Ebeid AM; Attia RR; Sundaram P; Fischer JE
    Am J Surg; 1979 Jan; 137(1):123-7. PubMed ID: 31806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of the axonal transport of vasoactive intestinal polypeptide (VIP) in nerves of the cat.
    Lundberg JM; Fahrenkrug J; Brimijoin S
    Acta Physiol Scand; 1981 Aug; 112(4):427-36. PubMed ID: 7315423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic metabolism of vasoactive intestinal polypeptide (VIP) in the rat.
    Brook CW; Sewell RB; Shulkes A; Smallwood RA
    Regul Pept; 1988 Apr; 20(4):311-22. PubMed ID: 3368582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.